Atlas Trials

A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy of Lavandula Angustifolia Containing Nasal Spray Medical Device in Preventing Deterioration of COVID-19 in Symptomatic Patients

Clinical trial NCT04974190 · UNKNOWN

Trial details

NCT number
NCT04974190
Sponsor
The Grasses of Eden Ltd
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
COVID-19 Infection
Start date
2021-08-01
Primary completion
2021-10-01
Enrollment
550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.